Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2012-000942-36 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to see whether antibiotics given at the start of laparoscopic kidney donation surgery prevent infection.
Subjects undergoing laparoscopic donor nephrectomy will be randomised to either a single dose of intravenous co-amoxiclav or placebo prior to surgery. Outcome measures include any infections, length of stay and costs
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Drug: co-amoxiclav | Experimental | experimental |
|
| Control | Placebo Comparator | comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Co-Amoxiclav | Drug | Will receive 1.2g co-amoxiclav at induction |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of infection after surgery | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Ultrasonic evidence of wound healing | Wounds will be assessed using high resolution ultrasound to assess dermal and epidermal healing. | 24 months |
| Length of hospital stay | 24 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nizam Mamode | Guy's and St Thomas' NHS Foundation Trust | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Guy's and St Thomas' NHS Foundation Trust | London | SE1 9RT | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D007239 | Infections |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019980 | Amoxicillin-Potassium Clavulanate Combination |
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D019818 | Clavulanic Acid |
| D002969 | Clavulanic Acids |
| D047090 | beta-Lactams |
| D007769 | Lactams |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Normal Saline | Drug | Placebo - 0.9% saline |
|
| Readmission rates | 24 months |
| Antibiotic associated side effects | Including diarrhoea and allergic reactions | 24 months |
| Return to work and normal activities | 24 months |
| Quality of life | 24 months |
| Relative costs | 24 months |
| D000577 |
| Amides |
| D009930 | Organic Chemicals |
| D000658 | Amoxicillin |
| D000667 | Ampicillin |
| D010400 | Penicillin G |
| D010406 | Penicillins |
| D013457 | Sulfur Compounds |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D004338 | Drug Combinations |
| D004364 | Pharmaceutical Preparations |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |